SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-470974
Filing Date
2013-12-12
Accepted
2013-12-12 10:20:00
Documents
9
Period of Report
2014-01-22
Effectiveness Date
2013-12-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d630729ddef14a.htm DEF 14A 533730
2 GRAPHIC g630729g19q78.jpg GRAPHIC 14027
3 GRAPHIC g630729g21o52.jpg GRAPHIC 16427
4 GRAPHIC g630729g42a74.jpg GRAPHIC 13888
5 GRAPHIC g630729g42j55.jpg GRAPHIC 35469
6 GRAPHIC g630729g47u93.jpg GRAPHIC 14183
7 GRAPHIC g630729g51p62.jpg GRAPHIC 14055
8 GRAPHIC g630729g74l38.jpg GRAPHIC 13853
9 GRAPHIC g630729g78x61.jpg GRAPHIC 14235
  Complete submission text file 0001193125-13-470974.txt   723618
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 131272547
SIC: 2835 In Vitro & In Vivo Diagnostic Substances